167 related articles for article (PubMed ID: 12659424)
1. Lymphokine-activated killer cells can kill target cells not only by early killing but also by late killing, and the late killing level against autotumor cell line.
Komatsu F; Ishiguro K
Oncol Res; 2003; 13(4):235-41. PubMed ID: 12659424
[TBL] [Abstract][Full Text] [Related]
2. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
3. Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.
Hong WS; Kim CM; Lee JO; Kang TW; Yun TK; Kim CY
Jpn J Clin Oncol; 1990 Mar; 20(1):87-93. PubMed ID: 2108272
[TBL] [Abstract][Full Text] [Related]
4. Cell-cell adhesion-independent killing due to lymphokine-activated killer cells against glioblastoma cell lines.
Komatsu F; Masuda T
Oncol Res; 2000; 12(9-10):371-81. PubMed ID: 11697816
[TBL] [Abstract][Full Text] [Related]
5. [Lymphokine-activated killer cell induced from cord blood].
Wang YF; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):78-81, 122-3. PubMed ID: 8033630
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.
Eisenthal A; Barbarsteyn E; Gitstein G; Lifschitz-Mercer B
Cancer Invest; 2006 Feb; 24(1):28-34. PubMed ID: 16466989
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killing by human intestinal lymphocytes.
Ebert EC; Roberts AI
Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
[TBL] [Abstract][Full Text] [Related]
8. [Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model].
Iwasaki K
Nihon Geka Hokan; 1990 Jan; 59(1):39-54. PubMed ID: 2130768
[TBL] [Abstract][Full Text] [Related]
9. Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer.
Wang ZP; Chen YR; Zheng RL; Lu JZ; Wang JJ
Acta Pharmacol Sin; 2002 Mar; 23(3):257-62. PubMed ID: 11918852
[TBL] [Abstract][Full Text] [Related]
10. Natural killer (NK) and lymphokine-activated killer (LAK) activities in a patient who recovered from cancer, and the characteristics of LAK cells generated from CD4-CD8- and CD8+ peripheral blood lymphocytes.
Komatsu F; Kihara K
Clin Immunol Immunopathol; 1995 Oct; 77(1):75-81. PubMed ID: 7554487
[TBL] [Abstract][Full Text] [Related]
11. Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model.
Iwasaki K; Kikuchi H; Miyatake S; Aoki T; Yamasaki T; Oda Y
Cancer Res; 1990 Apr; 50(8):2429-36. PubMed ID: 2317827
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cells.
Bean P; Agah R; Mazumder A
J Biol Response Mod; 1990 Feb; 9(1):92-7. PubMed ID: 2181073
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of lymphokine-activated killer cell activity by lentinan.
Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of cloned human lymphokine-activated killer (LAK) cells killing human leukemia cells in vitro].
Jiang CY
Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):163-6. PubMed ID: 1396052
[TBL] [Abstract][Full Text] [Related]
15. Human lymphokine-activated killer cells develop syngeneic killing ability.
Gallagher G; Findlay J; al-Azzawi FA
Immunology; 1989 Mar; 66(3):471-4. PubMed ID: 2784783
[TBL] [Abstract][Full Text] [Related]
16. Recognition of chromosome 6-associated target structures by human lymphokine-activated killer cells.
Helander T; Timonen T; Kalliomäki P; Schröder J
J Immunol; 1991 Sep; 147(6):2063-7. PubMed ID: 1890312
[TBL] [Abstract][Full Text] [Related]
17. [Electron microscopic observation on the killing of human lung carcinoma cells by lymphokine-activated killer cells (LAK cells) in vitro].
Shi J
Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):319-21, 22. PubMed ID: 2169980
[TBL] [Abstract][Full Text] [Related]
18. Cell surface recognition determinants involved in triggering the lymphokine activated killer cell phenomenon: enhanced killing of modified "anti-self" targets by varying LAK culture conditions.
Finkelstein DM; Miller RG
J Otolaryngol; 1990 Oct; 19(5):294-8. PubMed ID: 2262945
[TBL] [Abstract][Full Text] [Related]
19. Correlation between killing activity towards the murine L929 cell line and expression of membrane-associated lymphotoxin-related molecule of human lymphokine-activated killer cells.
Miyake M; Horiuchi A; Kimura K; Abe Y; Kimura S; Hitsumoto Y
Eur J Immunol; 1992 Aug; 22(8):2147-52. PubMed ID: 1639109
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
